How to buy Invitae Corporation stock

Invitae Corporation is a diagnostics & research business based in the US. Invitae Corporation shares (NVTA) are listed on the NYSE and all prices are listed in US Dollars. Invitae Corporation employs 2,100 staff and has a trailing 12-month revenue of around 0.00.

Invitae Corporation share price

Use our graph to track the performance of NVTA stocks over time.

Invitae Corporation shares at a glance

• Key figures

Information last updated 2021-04-23.

52-week range	$14.84 - $61.59
50-day moving average	$38.34
200-day moving average	$45.81
Wall St. target price	$53.50
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.87

Buy Invitae Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Invitae Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Invitae Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Invitae Corporation financials

Revenue TTM	$279.6 million
Gross profit TTM	$81.3 million
Return on assets TTM	-12.21%
Return on equity TTM	-51.12%
Profit margin	-215.37%
Book value	$10.63
Market capitalisation	$7.1 billion

TTM: trailing 12 months

Shorting Invitae Corporation shares

There are currently 28.3 million Invitae Corporation shares held short by investors – that's known as Invitae Corporation's "short interest". This figure is 4.6% up from 27.1 million last month.

There are a few different ways that this level of interest in shorting Invitae Corporation shares can be evaluated.

Invitae Corporation's "short interest ratio" (SIR)

Invitae Corporation's "short interest ratio" (SIR) is the quantity of Invitae Corporation shares currently shorted divided by the average quantity of Invitae Corporation shares traded daily (recently around 5.6 million). Invitae Corporation's SIR currently stands at 5.09. In other words for every 100,000 Invitae Corporation shares traded daily on the market, roughly 5090 shares are currently held short.

However Invitae Corporation's short interest can also be evaluated against the total number of Invitae Corporation shares, or, against the total number of tradable Invitae Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Invitae Corporation's short interest could be expressed as 0.14% of the outstanding shares (for every 100,000 Invitae Corporation shares in existence, roughly 140 shares are currently held short) or 0.1445% of the tradable shares (for every 100,000 tradable Invitae Corporation shares, roughly 145 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Invitae Corporation.

Find out more about how you can short Invitae Corporation stock.

Invitae Corporation share dividends

We're not expecting Invitae Corporation to pay a dividend over the next 12 months.

Invitae Corporation share price volatility

Over the last 12 months, Invitae Corporation's shares have ranged in value from as little as $14.84 up to $61.59. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Invitae Corporation's is 1.9741. This would suggest that Invitae Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Invitae Corporation overview

Invitae Corporation, a medical genetics company, integrates genetic information into healthcare decision-making by clinicians and patients in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California. .

Frequently asked questions

• What percentage of Invitae Corporation is owned by insiders or institutions?

  Currently 0.673% of Invitae Corporation shares are held by insiders and 83.566% by institutions.

• How many people work for Invitae Corporation?

  Latest data suggests 2,100 work at Invitae Corporation.

• When does the fiscal year end for Invitae Corporation?

  Invitae Corporation's fiscal year ends in December.

• Where is Invitae Corporation based?

  Invitae Corporation's address is: 1400 16th Street, San Francisco, CA, United States, 94103

• What is Invitae Corporation's ISIN number?

  Invitae Corporation's international securities identification number is: US46185L1035

• What is Invitae Corporation's CUSIP number?

  Invitae Corporation's Committee on Uniform Securities Identification Procedures number is: 46185L103